Company Statement: Grifols and Talecris Biotherapeutics announce the FTC has accepted the consent agreement for public comment
( June 1, 2011, 13:03 GMT | Official Statement) -- MLex Summary: Grifols and Talecris have announced the deal received official approval from the Federal Trade Commission after agreeing to divest certain assets to Italian rival, Kedrion. Company press release follows in full:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.